These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 26178210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS.
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [Abstract] [Full Text] [Related]

  • 7. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W, Zhang CQ, Shu HF, Yang MH, Yin Q, Yang H.
    J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
    [Abstract] [Full Text] [Related]

  • 8. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W, Kotulska K, Matyja E, Larysz-Brysz M, Mandera M, Roszkowski M, Domańska-Pakieła D, Lewik-Kowalik J, Jóźwiak S.
    Folia Neuropathol; 2008 May; 46(1):43-8. PubMed ID: 18368626
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K, Lucassen PJ, Spliet WG, Vreugdenhil E, van Rijen PC, Troost D, Jansen FE, Aronica E.
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A, Prabowo A, Anink J, Spliet WG, van Rijen PC, Aronica E.
    Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
    [Abstract] [Full Text] [Related]

  • 13. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH, Mahadeo T, Bordey A.
    J Neurosci; 2019 Apr 03; 39(14):2762-2773. PubMed ID: 30700531
    [Abstract] [Full Text] [Related]

  • 14. [Expression of autophagy-related proteins in cortical nodules of tuberous sclerosis complex].
    Ge HJ, Zhang WW, Wang YJ, Zhao LH, Hu ZL, Piao YS.
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov 08; 48(11):856-860. PubMed ID: 31775434
    [Abstract] [Full Text] [Related]

  • 15. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun 08; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

  • 16. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T, Kitaura H, Masuda H, Kameyama S, Saito Y, Sugai K, Otsuki T, Nakazawa A, Morota N, Yamamoto T, Iida K, Nakagawa M, Mizuno T, Takahashi H, Kakita A.
    Neuropathology; 2015 Oct 08; 35(5):401-9. PubMed ID: 25950494
    [Abstract] [Full Text] [Related]

  • 17. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T, Mühlebner A, Ricken G, Gruber V, Fabing A, Samueli S, Gröppel G, Dorfer C, Czech T, Hainfellner JA, Prabowo AS, Reinten RJ, Hoogendijk L, Anink JJ, Aronica E, Feucht M.
    Brain Pathol; 2017 Nov 08; 27(6):770-780. PubMed ID: 27750396
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with 18 F-FDG PET-CT values.
    Wang Z, Huang K, Yang X, Shen K, Yang L, Ruan R, Shi X, Wang M, Zhu G, Yang M, Zhang C, Lv S, Yang H, Fan X, Liu S.
    Brain Pathol; 2021 Mar 08; 31(2):346-364. PubMed ID: 33314369
    [Abstract] [Full Text] [Related]

  • 20. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
    Martinian L, Boer K, Middeldorp J, Hol EM, Sisodiya SM, Squier W, Aronica E, Thom M.
    Neuropathol Appl Neurobiol; 2009 Aug 08; 35(4):394-405. PubMed ID: 19508443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.